Zimmer Biomet to Acquire Paragon 28 (HSR Waiting Period Expires)

Elevance Health Acquires Paragon Healthcare

March 11, 2024

Healthcare Services

Elevance Health closed its acquisition of Paragon Healthcare, an infusion services and injectable therapy provider. Following the deal, Paragon Healthcare will operate as part of CarelonRx, Elevance’s pharmacy services segment, with plans to expand geographically and scale multi-site infusion services and specialty pharmacy capabilities.

AMETEK Acquires Paragon Medical from American Securities for ~$1.9B

October 31, 2023

Medical Devices

AMETEK, Inc. has agreed to acquire Paragon Medical, a Pierceton, Indiana-based contract manufacturer of medical components and instruments, from private equity firm American Securities in an all-cash transaction valued at approximately $1.9 billion. The deal advances AMETEK’s capabilities and footprint in medical device manufacturing and is subject to customary closing conditions and regulatory approvals.

Paragon 28 Acquires Disior

January 12, 2022

Medical Devices

Paragon 28, Inc. has acquired Disior Oy, a Helsinki-based developer of 3D analytics and pre-operative planning software for complex foot and ankle anatomy. Paragon 28 paid $18 million at closing with up to $8 million in contingent future payments; the closing payment was funded by drawing on its existing term loan facility.

Paragon 28 Acquires Assets of Additive Orthopaedics

June 1, 2021

Medical Devices

Paragon 28, Inc. acquired the product lines and related assets of Additive Orthopaedics, including the FDA‑cleared 3D‑printed patient‑specific talus spacer and an integrated cloud‑based pre‑operative surgical planning application. The acquisition expands Paragon 28’s foot‑and‑ankle product offering and accelerates its strategy to integrate smart tools, AI and advanced technologies to improve patient outcomes.

Peak Rock Capital Affiliate Acquires Paragon Healthcare, Inc.

September 15, 2020

Healthcare Services

An affiliate of Peak Rock Capital completed the acquisition of Paragon Healthcare, Inc., a provider of ambulatory and home infusion services and specialty pharmacy. Peak Rock said it will partner with Paragon's management to support geographic expansion and continued growth through organic initiatives and strategic acquisitions.

Catalent Acquires Paragon Bioservices for $1.2 Billion

May 20, 2019

Biotechnology

Catalent, Inc. completed the $1.2 billion acquisition of Paragon Bioservices, Inc., a viral vector development and manufacturing partner for gene therapies, expanding Catalent’s biologics and gene therapy capabilities. Paragon’s Baltimore-area facilities and ~380 employees will join Catalent’s global biologics platform, while Catalent secured financing including incremental term loans and a convertible preferred issuance to Leonard Green & Partners to support the transaction.